H.R. 747 Passed the House International Affairs

Stop Chinese Fentanyl Act of 2025

To impose sanctions with respect to Chinese producers of synthetic opioids and opioid precursors, to hold Chinese officials accountable for the spread of illicit fentanyl, and for other purposes.

  1. Introduced
  2. Committee
  3. Passed House
  4. Passed Senate
  5. To President
  6. Became law
Sponsor Rep. Barr, Andy [R-KY-6] Introduced January 28, 2025 Cosponsors 9 (7 R, 2 D) Latest action September 3, 2025

Summary

Stop Chinese Fentanyl Act of 2025
This bill subjects certain Chinese entities and government officials to potential sanctions related to opioid trafficking and requires the President to conduct certain preliminary analyses before regulating economic transactions in the event of a national emergency related to international drug trafficking. 
Specifically, for the purposes of the Fentanyl Sanctions Act, the bill changes the definition of foreign opioid trafficker to specify that the term includes (1) Chinese entities involved in the production or sale of synthetic opioids or related pharmaceutical ingredients that fail to take steps to detect or prevent opioid trafficking; and (2) certain senior Chinese government officials that aid and abet opioid trafficking, including through intentional inaction. Under current law, the President must impose certain sanctions on individuals and entities identified as foreign opioid traffickers.
Further, the bill extends through 2029 an existing requirement that the President report to Congress annually on identified foreign opioid traffickers and any sanctions imposed on them. (This requirement expired in December 2024.)
The bill also requires the President to take additional steps in issuing regulations under the International Emergency Economic Powers Act (IEEPA) pursuant to a declared national emergency related to international drug trafficking. (IEEPA authorizes the President to regulate a variety of economic transactions following a declaration of national emergency.) Under the bill, the President must evaluate the costs and benefits of issuing economic regulations for the purpose of resolving the drug trafficking emergency and publish a discussion of such costs and benefits.

Summary by the Congressional Research Service, Library of Congress.

Congress.gov

Roll-call votes

Actions

  1. Sep 3, 2025 Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
  2. Sep 2, 2025 Motion to reconsider laid on the table Agreed to without objection.
  3. Sep 2, 2025 On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220). (text: CR H3728-3729)
  4. Sep 2, 2025 Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220).
  5. Sep 2, 2025 Considered as unfinished business. (consideration: CR H3741-3742)
  6. Sep 2, 2025 At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  7. Sep 2, 2025 DEBATE - The House proceeded with forty minutes of debate on H.R. 747.
  8. Sep 2, 2025 Considered under suspension of the rules. (consideration: CR H3728-3731)
  9. Sep 2, 2025 Mr. Baumgartner moved to suspend the rules and pass the bill, as amended.
  10. Apr 9, 2025 Ordered to be Reported in the Nature of a Substitute by Voice Vote.
  11. Apr 9, 2025 Committee Consideration and Mark-up Session Held
  12. Mar 21, 2025 Reported (Amended) by the Committee on Financial Services. H. Rept. 119-19, Part I.

Congressional and federal records come from official public sources: the House Clerk, the U.S. Senate, GovInfo and the Library of Congress (bill status), the Federal Register, and the congress-legislators project. They are copied on a schedule and may lag the official record by a few hours; the official sources govern. News and coverage counts are drawn from the 4Search index and reflect what the press published, not 4Search's views. Nothing here is an endorsement of any candidate, party or position. Terms of use.